Researchers have recently found that a compound based on a spider toxin may be effective for treating pain.
Experiments conducted in rats revealed that the compound, called PnPP-19, provided pain relief most likely by acting on receptors in the nervous system that also bind opioids and cannabis (or marijuana).
Interestingly, PnPP-19 is also being studied as a drug candidate to treat erectile dysfunction.
Lead author Dr. Maria de Lima said their findings revealed that at least part of the mechanism of action underlying the pain relieving effects induced by PnPP-19.
Dr. Lima added that they also may contribute to the consideration of PnPP-19 as a potential lead compound for the development of new drug candidates to treat pain.
The study has been published in the British Journal of Pharmacology.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app